TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 35351716

Group type: EXPERIMENTAL
Intervention: Optimised digital behaviour change intervention delivered via app
Number of subjects: 205

Group type: COMPARATOR
Intervention: Active control group
Number of subjects: 205
Study: 33086387

Group type: EXPERIMENTAL
Intervention: Intra-arterial short-term infusion chemotherapy via angiocatheters or implanted arterial port catheters, infusion time of 7 to 12 minutes.
Number of subjects: 55
Study: 32881054

Group type: COMPARATOR
Intervention: Moderate-Intensity Continuous Exercise (MICE) - 35 minutes at 60%-65% of peak heart rate (HRmax)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High-Intensity Intermittent Exercise (HIIE 1) - 60×(8-s cycling-12-s recovery) at 80%-90% of HRmax
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: High-Intensity Intermittent Exercise (HIIE 2) - 10×1min at 80%-90% of HRmax - 1-min recovery
Number of subjects: 12
Study: 34958721

Group type: EXPERIMENTAL
Intervention: Hypertonic saline (5.8%) injection
Number of subjects: 34

Group type: COMPARATOR
Intervention: Isotonic saline (0.9%) injection
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Exercise (3 min isometric wall squat)
Number of subjects: 34
Study: 34704715

Group type: EXPERIMENTAL
Intervention: Medial branch block (MBB) during PKP surgery, injection of lidocaine and budesonide
Number of subjects: 198

Group type: EXPERIMENTAL
Intervention: Medial branch block (MBB) during PKP surgery
Number of subjects: 198

Group type: COMPARATOR
Intervention: Non-MBB group (normal saline injection during PKP surgery)
Number of subjects: 198
Study: 35416374

Group type: EXPERIMENTAL
Intervention: Two cycles of induction chemotherapy with platinum and docetaxel (TP) plus a Bcl‐2 inhibitor
Number of subjects: 54

Group type: COMPARATOR
Intervention: Single cycle induction chemotherapy with platinum and 5‐flurouracil (PF)
Number of subjects: 54
Study: 33628786

Group type: EXPERIMENTAL
Intervention: Ascaris lumbricoides
Number of subjects: 788

Group type: EXPERIMENTAL
Intervention: Hookworm
Number of subjects: 788

Group type: EXPERIMENTAL
Intervention: Trichuris trichiura
Number of subjects: 788

Group type: EXPERIMENTAL
Intervention: Capillaria hepatica
Number of subjects: 788

Group type: EXPERIMENTAL
Intervention: Double parasitism (Ascaris lumbricoides + Trichuris trichiura)
Number of subjects: 788

Group type: EXPERIMENTAL
Intervention: Triple parasitism (Ascaris lumbricoides + Trichuris trichiura + hookworm)
Number of subjects: 788

Group type: EXPERIMENTAL
Intervention: Overall prevalence
Number of subjects: 788

Group type: EXPERIMENTAL
Intervention: Infection by sex
Number of subjects: 788

Group type: EXPERIMENTAL
Intervention: Infection by age
Number of subjects: 788

Group type: EXPERIMENTAL
Intervention: Educational level
Number of subjects: 788

Group type: EXPERIMENTAL
Intervention: Fecal concentration of eggs
Number of subjects: 788
Study: 35209755

Group type: EXPERIMENTAL
Intervention: Highly objectified images of women in alcohol advertisements
Number of subjects: 1208

Group type: COMPARATOR
Intervention: Low-objectified images of women in alcohol advertisements
Number of subjects: 1208

Group type: EXPERIMENTAL
Intervention: Exposure to highly objectified advertisements
Number of subjects: 1208

Group type: EXPERIMENTAL
Intervention: Wishful identification with models in alcohol advertisements
Number of subjects: 1208

Group type: EXPERIMENTAL
Intervention: Perceived realism of alcohol ads
Number of subjects: 1208

Group type: EXPERIMENTAL
Intervention: Interaction between wishful identification and perceived realism
Number of subjects: 1208
Study: 34571605

Group type: EXPERIMENTAL
Intervention: Blink-Blink software with 8 reminders/min
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control group with 1 reminder/min
Number of subjects: 46
Study: 32758152

Group type: EXPERIMENTAL
Intervention: Manufactured UDCA (300 mg tablets and capsules)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Standard UDCA
Number of subjects: 30
Study: 34340911

Group type: EXPERIMENTAL
Intervention: Total polyphenol and flavonoid intake
Number of subjects: 6633

Group type: EXPERIMENTAL
Intervention: Lignan intake
Number of subjects: 6633

Group type: EXPERIMENTAL
Intervention: Stilbene intake
Number of subjects: 6633

Group type: EXPERIMENTAL
Intervention: Phenolic acid intake
Number of subjects: 6633

Group type: EXPERIMENTAL
Intervention: Other polyphenol classes
Number of subjects: 6633

Group type: EXPERIMENTAL
Intervention: Polyphenol intake in women
Number of subjects: 6633

Group type: EXPERIMENTAL
Intervention: Consumption of 'other polyphenols' class
Number of subjects: 6633
Study: 33113571

Group type: EXPERIMENTAL
Intervention: Apalutamide plus ADT
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus ADT
Number of subjects: 0
Study: 35088697

Group type: EXPERIMENTAL
Intervention: Weight loss intervention
Number of subjects: 49

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 49

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 49
Study: 33041172

Group type: EXPERIMENTAL
Intervention: Sensor-guided knee balancing
Number of subjects: 152

Group type: COMPARATOR
Intervention: Standard gap balancing (control)
Number of subjects: 152
Study: 32886868

Group type: EXPERIMENTAL
Intervention: Weight-bearing functional exercise
Number of subjects: 22

Group type: COMPARATOR
Intervention: Non-weight-bearing quadriceps strengthening exercise
Number of subjects: 22
Study: 33388532

Group type: EXPERIMENTAL
Intervention: CO2 digital subtraction angiography (DSA)
Number of subjects: 50

Group type: COMPARATOR
Intervention: ICM digital subtraction angiography (DSA)
Number of subjects: 50
Study: 33079238

Group type: COMPARATOR
Intervention: Conventional laparoscopic instruments (CLI)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Motorized articulating laparoscopic instruments (ALI)
Number of subjects: 50

Group type: EXPERIMENTAL
Intervention: Both CLI and ALI
Number of subjects: 50
Study: 33046461

Group type: EXPERIMENTAL
Intervention: Cataract surgical coverage (CSC) for persons with visual acuity <3/60
Number of subjects: 4078

Group type: EXPERIMENTAL
Intervention: Cataract surgeries with poor visual outcome
Number of subjects: 4078

Group type: EXPERIMENTAL
Intervention: Effective cataract surgical coverage (eCSC)
Number of subjects: 4078

Group type: EXPERIMENTAL
Intervention: Prevalence of blindness
Number of subjects: 4078

Group type: EXPERIMENTAL
Intervention: Prevalence of severe vision impairment
Number of subjects: 4078

Group type: EXPERIMENTAL
Intervention: Prevalence of moderate vision impairment
Number of subjects: 4078

Group type: EXPERIMENTAL
Intervention: Causes of blindness
Number of subjects: 4078

Group type: EXPERIMENTAL
Intervention: Most frequently reported barrier to cataract surgery
Number of subjects: 4078
Study: 85068751

Group type: EXPERIMENTAL
Intervention: Amantadine 100 mg
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Bromocriptine 2.5 + 2.5 mg
Number of subjects: 0

Group type: COMPARATOR
Intervention: Ethanol (1 g/kg)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Amantadine and bromocriptine (combined with ethanol)
Number of subjects: 0
Study: 35523116

Group type: EXPERIMENTAL
Intervention: Cissus quadrangularis 1.6 g/day (CQ1.6)
Number of subjects: 134

Group type: EXPERIMENTAL
Intervention: Cissus quadrangularis 1.2 g/day (CQ1.2)
Number of subjects: 134

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 134
Study: 34032127

Group type: EXPERIMENTAL
Intervention: Ultrasound-accelerated catheter-directed thrombolysis
Number of subjects: 120

Group type: COMPARATOR
Intervention: Standard treatment alone
Number of subjects: 120
Study: 34137830

Group type: EXPERIMENTAL
Intervention: Volar locking plate system (VLPS)
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: External fixation with or without supplementary pinning (EFP)
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: Percutaneous pinning (CRPP)
Number of subjects: 304

Group type: COMPARATOR
Intervention: Closed reduction and casting
Number of subjects: 304

Group type: COMPARATOR
Intervention: Casting
Number of subjects: 304

Group type: EXPERIMENTAL
Intervention: All groups
Number of subjects: 304
Study: 32007650

Group type: EXPERIMENTAL
Intervention: 18F‐FDG‐PET‐CT in PMR patients
Number of subjects: 101

Group type: COMPARATOR
Intervention: Control group (non-PMR population)
Number of subjects: 101
Study: 34978133

Group type: EXPERIMENTAL
Intervention: PRP prepared by digital centrifuge, large-sized sodium citrate tube, and low centrifugation speed (900 rpm)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: PRP treatment (all groups)
Number of subjects: 40

Group type: COMPARATOR
Intervention: PRP prepared by different methods (4 groups)
Number of subjects: 40
Study: 34375388

Group type: EXPERIMENTAL
Intervention: Weight loss diet intervention
Number of subjects: 457
Study: 34710240

Group type: EXPERIMENTAL
Intervention: Oscillating chitosan brush
Number of subjects: 78

Group type: COMPARATOR
Intervention: Regular curettes
Number of subjects: 78
Study: 32621657

Group type: EXPERIMENTAL
Intervention: Hyaluronic acid injections using a stamp-type microneedle (Dermashine balance)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Placebo injections
Number of subjects: 60
Study: 35938326

Group type: EXPERIMENTAL
Intervention: Naochang Tongtiao acupuncture
Number of subjects: 64

Group type: COMPARATOR
Intervention: Conventional acupuncture
Number of subjects: 64
Study: 33359375

Group type: EXPERIMENTAL
Intervention: Glucocorticoids
Number of subjects: 0
Study: 35113582

Group type: EXPERIMENTAL
Intervention: Prevention and Relationship Education Program (PREP)
Number of subjects: 242
Study: 32048170

Group type: EXPERIMENTAL
Intervention: MQFRMP (Modified Qufeng Runmian Powder)
Number of subjects: 220

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 220
Study: 36450853

Group type: EXPERIMENTAL
Intervention: Whole body massage
Number of subjects: 74

Group type: COMPARATOR
Intervention: Oral 10% dextrose
Number of subjects: 74

Group type: COMPARATOR
Intervention: Kangaroo care
Number of subjects: 74
Study: 33615641

Group type: EXPERIMENTAL
Intervention: 10 mM denatonium benzoate solution (0.1 ml/kg)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (water, identical volume)
Number of subjects: 20
Study: 32059641

Group type: EXPERIMENTAL
Intervention: Collaborative quality improvement program
Number of subjects: 10000

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 10000
Study: 34399643

Group type: EXPERIMENTAL
Intervention: Infographics
Number of subjects: 280

Group type: COMPARATOR
Intervention: Text
Number of subjects: 280
Study: 33502122

Group type: EXPERIMENTAL
Intervention: High-protein diet (30% protein, 40% carbohydrates, 30% fat)
Number of subjects: 76

Group type: COMPARATOR
Intervention: Standard-protein diet (15% protein, 55% carbohydrates, 30% fat)
Number of subjects: 76
Study: 33112544

Group type: EXPERIMENTAL
Intervention: 3D-HD laparoscope
Number of subjects: 120

Group type: COMPARATOR
Intervention: 2D-HD laparoscope
Number of subjects: 120
Study: 36328387

Group type: EXPERIMENTAL
Intervention: Diagnostic laparoscopy with excision of endometrial tissue (active surgery)
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Purely diagnostic laparoscopy (sham surgery)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Delayed surgery (no-surgery control group)
Number of subjects: 100
Study: 35662680

Group type: EXPERIMENTAL
Intervention: Parenting Acceptance and Commitment Therapy (PACT)
Number of subjects: 67
Study: 32706692

Group type: EXPERIMENTAL
Intervention: Internet-based self-management support in addition to usual care (n=33)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Usual care only (n=29)
Number of subjects: 62
Study: 36153482

Group type: EXPERIMENTAL
Intervention: Invitation letter with researcher photographs (IG)
Number of subjects: 9990

Group type: COMPARATOR
Intervention: Invitation letter without photographs (CG)
Number of subjects: 9990
Study: 34784247

Group type: EXPERIMENTAL
Intervention: Metformin treatment with acute exercise
Number of subjects: 44

Group type: EXPERIMENTAL
Intervention: 12 weeks of exercise training
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (no metformin) with acute exercise
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control group (no metformin) with 12 weeks of exercise training
Number of subjects: 44
Study: 34590924

Group type: EXPERIMENTAL
Intervention: Hand-assisted laparoscopic surgery (HALS)
Number of subjects: 124

Group type: COMPARATOR
Intervention: Open surgery (OS)
Number of subjects: 124
Study: 32019700

Group type: EXPERIMENTAL
Intervention: 0.05% atropine
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: 0.025% atropine
Number of subjects: 383

Group type: EXPERIMENTAL
Intervention: 0.01% atropine
Number of subjects: 383

Group type: COMPARATOR
Intervention: 0.05% atropine (phase 1 placebo switched to 0.05% in second year)
Number of subjects: 383
Study: 35262718

Group type: EXPERIMENTAL
Intervention: Daily low-dose aspirin (81 mg) taken at least 5 of 7 days per week for at least 80% of follow-up time
Number of subjects: 1227

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1227
Study: 33852732

Group type: EXPERIMENTAL
Intervention: Yellow cassava pasta enriched with amaranth vegetable
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Yellow cassava pasta
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Ugwu (Telfairia occidentalis)
Number of subjects: 0
Study: 35894657

Group type: EXPERIMENTAL
Intervention: C21 (200 mg)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 33200309

Group type: EXPERIMENTAL
Intervention: Laparoscopic Sleeve Gastrectomy (LSG)
Number of subjects: 201

Group type: COMPARATOR
Intervention: One-Anastomosis Gastric Bypass (OAGB)
Number of subjects: 201
Study: 32331922

Group type: EXPERIMENTAL
Intervention: Activated photochromic lens
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Inactivated photochromic lens
Number of subjects: 60

Group type: COMPARATOR
Intervention: Non‐photochromic lens
Number of subjects: 60
Study: 32079891

Group type: EXPERIMENTAL
Intervention: Open reduction
Number of subjects: 234

Group type: COMPARATOR
Intervention: Closed reduction
Number of subjects: 234
Study: 36327320

Group type: EXPERIMENTAL
Intervention: DNA/AIDSVAX BE
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DNA/CN54gp140
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: daily oral PrEP
Number of subjects: 0

Group type: COMPARATOR
Intervention: placebo control
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: daily Truvada
Number of subjects: 0
Study: 33369459

Group type: EXPERIMENTAL
Intervention: Airway Block (n=30) - Superior laryngeal nerve block bilaterally and recurrent laryngeal nerve block transtracheally with Inj 2% Lignocaine
Number of subjects: 60

Group type: COMPARATOR
Intervention: Airway Nebulization (n=30) - Airway nebulized with 4% Lignocaine with ultrasonic nebulizer
Number of subjects: 60
Study: 35614028

Group type: EXPERIMENTAL
Intervention: EUS-FNA with self-ROSE
Number of subjects: 194

Group type: COMPARATOR
Intervention: EUS-FNA without self-ROSE (non-self-ROSE group)
Number of subjects: 194
Study: 32976362

Group type: EXPERIMENTAL
Intervention: Risk reduction counseling
Number of subjects: 1050

Group type: COMPARATOR
Intervention: STI health education control condition
Number of subjects: 1050

Group type: COMPARATOR
Intervention: Enhanced partner notification counseling
Number of subjects: 1050
Study: 32541643

Group type: EXPERIMENTAL
Intervention: Valsartan (ARB group)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 0
Study: 36079758

Group type: EXPERIMENTAL
Intervention: Ultrasound (U group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Radiofrequency (RF group)
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Combined radiofrequency and ultrasound (RF/U group)
Number of subjects: 60
Study: 32886181

Group type: EXPERIMENTAL
Intervention: scHA/budesonide
Number of subjects: 30

Group type: COMPARATOR
Intervention: scHA
Number of subjects: 30
Study: 36328945

Group type: EXPERIMENTAL
Intervention: Progressive Muscle Relaxation (PMR)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no PMR)
Number of subjects: 0
Study: 32687819

Group type: EXPERIMENTAL
Intervention: Behavioral weight loss intervention (health coaching phone sessions weekly for 6 months, then monthly for 18 months or until end of pregnancy)
Number of subjects: 326

Group type: COMPARATOR
Intervention: Usual care control
Number of subjects: 326

Group type: EXPERIMENTAL
Intervention: Behavioral weight loss intervention
Number of subjects: 326
Study: 35329133

Group type: EXPERIMENTAL
Intervention: Telephone follow-up (test)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional personal aftercare (control)
Number of subjects: 60
Study: 36324088

Group type: EXPERIMENTAL
Intervention: Active tACS plus VST (visual scanning training)
Number of subjects: 22

Group type: COMPARATOR
Intervention: Sham (placebo) tACS plus VST (visual scanning training)
Number of subjects: 22
Study: 33691499

Group type: EXPERIMENTAL
Intervention: M. vaccae in combination with standard care
Number of subjects: 31

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 31
Study: 36083814

Group type: EXPERIMENTAL
Intervention: Daily intravenous infusions of ozonized saline with ozone concentration of 2.0 mg/l for 5 days followed by standard rehabilitation (n=18)
Number of subjects: 51

Group type: EXPERIMENTAL
Intervention: 5 ozone therapy procedures every other day (n=16)
Number of subjects: 51

Group type: COMPARATOR
Intervention: Control group with a 10-day course of daily breathing exercises and physiotherapy for the lungs (n=17)
Number of subjects: 51
Study: 36048457

Group type: EXPERIMENTAL
Intervention: Telaglenastat plus Cabozantinib (Tela + Cabo)
Number of subjects: 444

Group type: COMPARATOR
Intervention: Placebo plus Cabozantinib (Pbo + Cabo)
Number of subjects: 444
Study: 33020113

Group type: EXPERIMENTAL
Intervention: Supervised airway clearance techniques (ACT) lasting 30-60 min
Number of subjects: 64

Group type: COMPARATOR
Intervention: Rest
Number of subjects: 64
Study: 35973593

Group type: EXPERIMENTAL
Intervention: 577nm subthreshold micropulse laser (SML)
Number of subjects: 266

Group type: COMPARATOR
Intervention: Standard laser (SL)
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: SML
Number of subjects: 266

Group type: EXPERIMENTAL
Intervention: SML and SL
Number of subjects: 266
Study: 33798494

Group type: EXPERIMENTAL
Intervention: Prophylactic surgical closure of the left atrial appendage
Number of subjects: 1040
Study: 32232974

Group type: EXPERIMENTAL
Intervention: Androgen deprivation therapy (ADT)
Number of subjects: 20
Study: 35925157

Group type: EXPERIMENTAL
Intervention: PMD200 monitoring with sufentanil bolus administered when NoL index > 25 for 2 min (n=24)
Number of subjects: 50

Group type: COMPARATOR
Intervention: Standardized sufentanil bolus administered at anesthesiologist's discretion (n=26)
Number of subjects: 50
Study: 32222430

Group type: EXPERIMENTAL
Intervention: Definitive thoracic radiation therapy (RT) administered once or twice daily for LS-SCLC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Adjuvant RT in surgically resected patients with positive margins or nodal metastases
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Involved field RT using conformal advanced treatment modalities to postchemotherapy volumes
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Stereotactic body radiation therapy (SBRT) or conventional fractionation for stage I or II node negative disease
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prophylactic cranial irradiation (PCI) for LS-SCLC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Consultation for consideration of PCI versus magnetic resonance surveillance in ES-SCLC
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Thoracic RT in select patients with ES-SCLC after chemotherapy treatment
Number of subjects: 0
Study: 34388698

Group type: EXPERIMENTAL
Intervention: Palbociclib (125 mg/d on a 3 weeks on/1 week off schedule) plus letrozole (2.5 mg/d, continuous)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo plus letrozole
Number of subjects: 0
Study: 32629906

Group type: EXPERIMENTAL
Intervention: Gluten-free, low FODMAP diet during elimination phase
Number of subjects: 11
Study: 33801216

Group type: EXPERIMENTAL
Intervention: Wearable focal muscle vibration (FMV) therapy applied using a modified MyovoltTM device, 3 days a week for 4 weeks
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Wearable focal muscle vibration (FMV) therapy
Number of subjects: 23
Study: 33046199

Group type: EXPERIMENTAL
Intervention: Antibiotic treatment
Number of subjects: 2

Group type: EXPERIMENTAL
Intervention: Low back pain with Modic changes
Number of subjects: 2

Group type: COMPARATOR
Intervention: Bacterial presence in discs
Number of subjects: 2
Study: 35837739

Group type: EXPERIMENTAL
Intervention: Dupilumab
Number of subjects: 422

Group type: COMPARATOR
Intervention: Omalizumab
Number of subjects: 422
Study: 33446157

Group type: EXPERIMENTAL
Intervention: Educational program based on Theory of Planned Behavior (TPB)
Number of subjects: 94

Group type: COMPARATOR
Intervention: Control group (no educational program)
Number of subjects: 94
Study: 35655286

Group type: EXPERIMENTAL
Intervention: Zhizhu Kuanzhong Capsule (ZZKZ)
Number of subjects: 480

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 480
Study: 32070297

Group type: EXPERIMENTAL
Intervention: HIV self‐Testing intervention with free HIVST kits provided every 30 days
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not explicitly mentioned in the abstract)
Number of subjects: 0
Study: 36194923

Group type: EXPERIMENTAL
Intervention: Oxytocin
Number of subjects: 51

Group type: COMPARATOR
Intervention: Promestriene
Number of subjects: 51
Study: 33610123

Group type: EXPERIMENTAL
Intervention: Chemotherapy with concurrent cediranib, followed by maintenance cediranib (arm C)
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Chemotherapy with concurrent cediranib, followed by maintenance placebo (arm B)
Number of subjects: 456

Group type: COMPARATOR
Intervention: Chemotherapy with placebo throughout (arm A, reference)
Number of subjects: 456
Study: 32218424

Group type: EXPERIMENTAL
Intervention: Hoodia Parviflora (H. Parviflora) at 9 mg + 200 mg of fructo‐oligosaccharides, taken twice a day for 4 weeks
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Hoodia Parviflora (H. Parviflora)
Number of subjects: 30

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 30
Study: 35989963

Group type: EXPERIMENTAL
Intervention: Conventional rehabilitation + robot-assisted hand therapy (HandTutor) for 1 hour during each session, 3 h/day, 2 days/week for 5 weeks
Number of subjects: 33

Group type: COMPARATOR
Intervention: Conventional rehabilitation alone for 3 h/day, 2 days/week for 5 weeks
Number of subjects: 33
Study: 33030570

Group type: EXPERIMENTAL
Intervention: Lipid-lowering medications (LLMs)
Number of subjects: 7592

Group type: EXPERIMENTAL
Intervention: Lipophilic statins
Number of subjects: 7592

Group type: EXPERIMENTAL
Intervention: Hydrophilic statins
Number of subjects: 7592